Inflammatory bowel disease (IBD) refers to diseases characterized by chronic inflammation of the gastrointestinal tract. The most common are Crohn’s disease and ulcerative colitis. Chronic chronic inflammation can impair the normal functioning of affected gastrointestinal organs, leading to symptoms such as persistent diarrhea, abdominal pain, rectal bleeding, weight loss… Continue Reading Inflammatory bowel disease in-depth report: current therapies, new drug pipelines and prospects

  Sulfasalazine, mesalazine, olsalazine, and balsalazide are the main drugs for the treatment of inflammatory bowel disease (IBD), but the four drugs are very different. Only by mastering the differences between them can the drug be selected correctly.   I. Ulcerative colitis, the difference between Crohn’s disease If you don’t… Continue Reading The difference between sulfasalazine, mesalazine, olsalazine…